COVID-19 Update:Learn more about how we are protecting our patients, families and staff, as well as other important facts about COVID-19.
Five finalists have been named in the prestigious annual “Make Your Medical Device Pitch for Kids!” competition presented by the National Capital Consortium for Pediatric Device Innovation (NCC-PDI). Representing innovations in electrophysiology devices that treat congenital heart disease (CHD) and arrhythmias in pediatric patients, these five finalists now have access to a pediatric accelerator program led by MedTech Innovator and will compete for a share of $150,000 in grant funding from the U.S. Food and Drug Administration (FDA) in the final virtual pitch event in September 2021. The pediatric pitch event is part of the 9th Annual Symposium on Pediatric Device Innovation, co-located with the MedTech Conference, powered by AdvaMed.
Mothers who are Hispanic or who come from rural or low socioeconomic status neighborhoods are less likely to have their child’s critical heart condition diagnosed before birth, according to a new study in the journal Circulation.
According to data from a cohort of adult and pediatric patients with antibody deficiencies, patients that often fail to make protective immune responses to infections and vaccinations showed robust T-cell activity and humoral immunity against SARS-CoV-2 structural proteins. The new study, led by researchers at Children’s National Hospital, is the first to demonstrate a robust T-cell response against SARS-CoV-2 in immunocompromised patients.
In honor of National Therapy Animal Day, Children’s National Hospital today announced a new grant from PetSmart Charities to enhance the hospital’s Animal Visitation and Pet Therapy Program. The grant supports the program’s two on-staff therapy dogs, as well as the recruitment and management of volunteer dog handler teams.
The District’s largest solar canopy was unveiled on the grounds of the Children’s National Research & Innovation Campus. The canopy will provide more than 325 income-qualified households with clean, renewable energy and electricity bill savings over the next 15 years.
The National Institute of Allergy and Infectious Diseases (NIAID) allocated $10 million in funding to establish the Childhood Asthma in the Urban Setting (CAUSE) network. The NIAID plans to increase this number by $70 million over seven years to support the network. Children’s National Hospital will be part of the new research network, which is a 7-year consortium comprised of seven clinical sites in six different cities that will join forces to perform mechanistic and translational studies examining the basic immunology of pediatric asthma among urban, under-resourced, and largely minority children and adolescents.
PCORI has awarded $4.8 million to investigators at the Louisiana Public Health Institute and Children’s National Hospital to study how gaps in health care affect the health and well-being of adults with congenital heart disease.
Following an extensive nationwide search, Children’s National Hospital has named Michelle McGuire, M.B.A., executive vice president (EVP) and chief strategy officer (CSO).
A recent study published in Pediatrics found that the COVID-19 pandemic is associated with a surge in firearm injuries in young children and inflicted by young children. The findings, led by Children’s National Hospital experts, show that the COVID-19 pandemic is associated with a surge in fatal and nonfatal firearm injuries both in young children and inflicted by young children.
Congenital heart disease (CHD) affects six out of 1,000 babies born in the U.S. each year and is often complicated by arrhythmias, a condition where the heart beats too rapidly, too slowly or irregularly due to a misfiring of the body’s electrical impulses. While the last decade brought great advances in technologies that improve the care of adult arrhythmias, pediatric patients have been left behind, with only five devices approved for use in children in the same period. As a result, pediatric specialists are often using off-label or improvised devices to treat pediatric arrhythmias, including in the smallest newborns.